Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Agrin Moeini(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Giancarlo Castellano(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Daniela Sia(Icahn School of Medicine at Mount Sinai), Maria Isabel Fiel(Icahn School of Medicine at Mount Sinai), Parissa Tabrizian(Mount Sinai Hospital), Laia Cabellos(Icahn School of Medicine at Mount Sinai), Lewis R. Roberts(Mayo Clinic), Roser Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Beatriz Mínguez, Judit Peix, M. Schwartz(Tisch Hospital), Carlos Villacorta-Martín(Icahn School of Medicine at Mount Sinai), Christine Sempoux, Leonardo Rodríguez‐Carunchio(Hospital Clínic de Barcelona), Timothy M. Pawlik(The Ohio State University), Augusto Villanueva(NYU Langone Health), Ismaïl Labgaa(University Hospital of Lausanne), Manel Solé(Hospital Clínic de Barcelona), Miguel Torres‐Martín(Tisch Hospital), Wei Qiang Leow(SingHealth), Josep Fuster(Hospital Universitario Son Espases), Laia Bassaganyas(Universitat Pompeu Fabra), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Miho Maeda, Carla Montironi(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Sasan Roayaie(White Plains Hospital), Roger Esteban-Fabró(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 301
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k